Moderna is rated a Hold, citing valuation concerns, lack of definitive long-term efficacy data, and significant execution and ...
A 354-page report profiles 36 companies, including Abbott, bioMérieux, Roche and Thermo Fisher, across respiratory, gastrointestinal and meningitis testing in 15 countries — though costs and shifting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results